Private Markets, Angel and Secondary Investing, Sacra

Sacra

Private Markets, Angel and Secondary Investing

Bringing transparency to private markets so investors, founders, and employees can build on conviction. Sacra delivers deeply researched insights on the private companies shaping tomorrow's markets. By surfacing the data, context, and operator perspective that are missing from private markets today, we help secondary buyers and sellers price equity accurately and unlock liquidity for the people building these businesses.

Private Capital Markets

Colossal Biosciences / Private Capital Markets

<ul><li>Colossal Biosciences was valued at approximately $10.2 billion following a $200M Series C in January 2025.</li><li>The company sells through three channels.</li><li>Colossal Biosciences is expanding from de-extinction into species engineering and conservation infrastructure.</li></ul>

Colossal Biosciences was valued at approximately $10.2 billion following a $200M Series C in January 2025.The company sells through three channels.Colossal Biosciences is expanding from de-extinction into species engineering and conservation infrastructure.

Primer: Colossal Biosciences - 02 Sep 2026

United States

Advanced genetic engineering and de-extinction research using CRISPR and reproductive technologies to functionally revive extinct species and support conservation

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Colossal Biosciences (BIOSCIENCES US)

Primer: Colossal Biosciences - 02 Sep 2026

Advanced genetic engineering and de-extinction research using CRISPR and reproductive technologies to functionally revive extinct species and...

Sacra

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)